
Moxynek-CV 625 Tablet
Marketer
Shatayushi Healthcare Pvt Ltd
Salt Composition
Amoxycillin (500mcg) + Clavulanic Acid (125mg)
Overview Moxynek-CV 625 Tablet
Cefixime 625mg tablets are a bacterial infection fighter, combating infections in various areas including the lungs (like pneumonia), ears, sinuses, urinary tract, skin, and soft tissues. Ineffective against viral illnesses such as colds, this antibiotic is optimally absorbed when taken with food to minimize stomach discomfort. Follow your physician's prescribed dosage schedule, ensuring consistent, evenly spaced intervals for best results. Consistent daily timing aids adherence. Treatment duration should be as directed; incomplete courses may lead to recurring or intensified infections due to surviving bacteria. Common, usually mild, side effects can include nausea, diarrhea, vomiting, oral or genital yeast infections, skin rashes, and vaginal infections. Report persistent or bothersome side effects to your doctor. Prior to use, disclose any antibiotic allergies, kidney or liver issues, and all other medications currently in use to your doctor or pharmacist, as interactions are possible. This medication is generally safe during pregnancy and breastfeeding under medical supervision.
Primary Ingredients of Moxynek-CV 625 Tablet
The provided text is "undefined," so there is nothing to rephrase.
Uses of Moxynek-CV 625 Tablet
Combating Bacterial Infections
Major Benefits of Moxynek-CV 625 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Moxynek-CV 625 Tablet with a meal.
Common Side effects of Moxynek-CV 625 Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Moxynek-CV 625 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Moxynek-CV 625 Tablet with a meal.
How Moxynek-CV 625 Tablet works:
Amoxycillin and clavulanate potassium, combined as Moxynek-CV 625 Tablet, offer a dual-action approach to bacterial infections. Amoxycillin, an antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Clavulanate potassium, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Amoxycillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Moxynek-CV 625 Tablets poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Moxynek-CV 625 Tablet is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, Moxynek-CV 625 Tablet is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Moxynek-CV 625 Tablets, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should use Moxynek-CV 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Moxynek-CV 625 Tablets are contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Moxynek-CV 625 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Liver function should be regularly assessed during treatment.
What if you forget to take Moxynek-CV 625 Tablet :
Should you forget a dose of Moxynek-CV 625 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Moxynek-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
